Home » Topics » Regulatory » Patents

Patents
RSS

Abbott presents GSK-3beta inhibitors for the treatment of Alzheimer's disease

Dec. 10, 2009

Bayer Schering Pharma claims novel HIF prolyl hydroxylase inhibitors

Dec. 10, 2009

Novel platinum compounds disclosed by sanofi-aventis for cancer therapy

Dec. 10, 2009

Novel ZAP-70 inhibitors in early development at Cellzone

Dec. 10, 2009

Novel GK activators claimed by Roche as antidiabetic agents

Dec. 9, 2009

Intellikine describes novel PI3K and mTOR inhibitors for the treatment of cancer

Dec. 9, 2009

Takeda discloses novel ACC inhibitors for the treatment of obesity

Dec. 9, 2009

Novel S1P1/edg1 receptor agonists in early development at Actelion

Dec. 9, 2009

Panacea Biotec claims novel compounds for the treatment of bacterial infections

Dec. 9, 2009

German scientists describe novel ClpP inhibitors as antibacterial agents

Dec. 7, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...